Recent research suggests that metformin, a medicine used to treat type 2 diabetes, may have the ability to slow down the aging process by activating cellular pathways through AMPK that promote youthful cellular functioning, making it a promising candidate for an anti-aging drug. This is particularly good news for individuals with diabetes, as high blood glucose levels not only cause insulin resistance but also accelerate the aging process. Furthermore, studies have shown that metformin has benefits beyond regulating glucose levels and treating diabetes, including protection against cancer and cardiovascular disease, neuroprotection, and weight loss by regulating AMPK-activated pathways that promote healthy metabolism.
Is it possible that a commonly used medication for diabetes could also have anti-aging benefits?
No comments:
Post a Comment